intuniv
takeda pharmaceuticals international ag ireland branch - guanfacin hydroklorid - attention deficit disorder med hyperaktivitet - antiadrenergic agents, centrally acting, antihypertensives, - intuniv is indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children and adolescents 6 17 years old for whom stimulants are not suitable, not tolerated or have been shown to be ineffective. intuniv må brukes som en del av en omfattende adhd behandling program, vanligvis inkludert psykologiske, pedagogiske og sosiale tiltak.
lynparza 100 mg
abacus medicine a/s - olaparib - tablett, filmdrasjert - 100 mg
diacomit 250 mg
abacus medicine a/s - stiripentol - kapsel, hard - 250 mg
diacomit 500 mg
abacus medicine a/s - stiripentol - kapsel, hard - 500 mg
abraxane 5 mg/ ml
abacus medicine a/s - paklitaksel - pulver til infusjonsvæske, suspensjon - 5 mg/ ml
hepsera 10 mg
abacus medicine a/s - adefovirdipivoksil - tablett - 10 mg
sprycel 20 mg
abacus medicine a/s - dasatinibmonohydrat - tablett, filmdrasjert - 20 mg
sprycel 50 mg
abacus medicine a/s - dasatinibmonohydrat - tablett, filmdrasjert - 50 mg
sprycel 70 mg
abacus medicine a/s - dasatinibmonohydrat - tablett, filmdrasjert - 70 mg
viramune 400 mg
abacus medicine a/s - nevirapin - depottablett - 400 mg